Amneal launches generic Gabitril
Amneal Pharmaceuticals has introduced its generic Gabitril (tiagabine hydrochloride) tablets. The drug is indicated to as an adjunctive treatment for partial seizures in patients ages 12 years and older.
Bridgewater, N.J.-based Amneal’s generic Gabitril tablets will be available in 2-, 4-, 12- and 16-mg dosage strengths. The product had a market size of roughly $30 million for the 12 months ended January 2018, according to IQVIA data.
Bridgewater, N.J.-based Amneal’s generic Gabitril tablets will be available in 2-, 4-, 12- and 16-mg dosage strengths. The product had a market size of roughly $30 million for the 12 months ended January 2018, according to IQVIA data.